These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18179917)

  • 1. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis.
    Matsuguma H; Nakahara R; Igarashi S; Ishikawa Y; Suzuki H; Miyazawa N; Honjo S; Yokoi K
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):44-9. PubMed ID: 18179917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
    Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS
    J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
    Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
    Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
    Buccheri G; Ferrigno D
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage?
    Kawachi R; Nakazato Y; Takei H; Koshi-ishi Y; Goya T
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):199-202. PubMed ID: 19457896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: differences according to histology and smoking status.
    Kato T; Ishikawa K; Aragaki M; Sato M; Okamoto K; Ishibashi T; Oba K; Kaji M
    J Surg Oncol; 2013 May; 107(6):619-24. PubMed ID: 23192365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological study of p-T1aN0M0 non-small-cell lung cancer, as defined in the seventh edition of the TNM classification of malignant tumors.
    Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):963-7. PubMed ID: 20951601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
    Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the serum carcinoembryonic antigen level during the follow-up of patients with completely resected non-small-cell lung cancer.
    Ozeki N; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ito S; Sakao Y; Mitsudomi T; Hirakawa A; Yokoi K
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):687-92. PubMed ID: 23979987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer.
    Lin Q; Li M; Shen ZY; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M
    Jpn J Clin Oncol; 2010 Jul; 40(7):670-6. PubMed ID: 20382636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients.
    Ichinose Y; Hara N; Ohta M; Yano T; Maeda K; Asoh H; Katsuda Y
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):90-4. PubMed ID: 8391613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non-small cell lung cancer.
    Kuo SW; Chen JS; Huang PM; Hsu HH; Lai HS; Lee JM
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1200-1207.e3. PubMed ID: 24993621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer.
    Tomita M; Shimizu T; Ayabe T; Yonei A; Onitsuka T
    Anticancer Res; 2010 Jul; 30(7):3099-102. PubMed ID: 20683062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen level in serum and pleural lavage fluid in non-small cell lung cancer.
    Tomita M; Shimizu T; Ayabe T; Yonei A; Onitsuka T
    Thorac Cardiovasc Surg; 2010 Sep; 58(6):350-3. PubMed ID: 20824588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer.
    Kessler R; Gasser B; Massard G; Roeslin N; Meyer P; Wihlm JM; Morand G
    Ann Thorac Surg; 1996 Nov; 62(5):1489-93. PubMed ID: 8893589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of determination of the serum carcinoembryonic antigen in oncopulmonology].
    Lazarev SM; Reshetov AV; Nikolaev GV; Volgin GN; Nokhrin AV; Kokorin DM
    Vestn Khir Im I I Grek; 2009; 168(3):21-5. PubMed ID: 19663274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer.
    Yilmaz A; Duyar SS; Cakir E; Aydin E; Demirag F; Karakaya J; Yazici U; Erdogan Y
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):664-70. PubMed ID: 21334917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical indications for small advanced lung cancer: especially from resected cases of peripheral non-small cell lung cancer less than 2 cm in diameter].
    Imaizumi M; Ojika T; Abe T
    Kyobu Geka; 1991 Jan; 44(1):18-22. PubMed ID: 1645418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination.
    Yamashita JI; Kurusu Y; Fujino N; Saisyoji T; Ogawa M
    J Thorac Cardiovasc Surg; 2000 May; 119(5):899-905. PubMed ID: 10788810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.